Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
ImClone Systems
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Compassionate use controversy== The FDA approved the aforementioned colorectal cancer drug, [[Cetuximab|Erbitux]], on February 12, 2004. In May 2001, while ImClone was still seeking approval for the drug (then known as IMC-C225), the CBS news program "60 Minutes" aired a story about two cancer patients' struggles to obtain [[Expanded access|"compassionate use"]] of the drug. One ultimately succeeded; the other failed despite repeated pleas to ImClone officials. It was alleged in the story that ImClone was arbitrary in who received the drug and had no written criteria for compassionate use.<ref>{{cite web |url=https://www.fda.gov/ola/2001/compassionateuse0620.html |title=Statement by Robert Temple, M.D., Associate Director for Center for Drug Evaluation and Research, Food and Drug Administration Before the Committee on Government Reform, U.S. House of Representatives |date=June 20, 2001|archive-url = https://web.archive.org/web/20010820232418/https://www.fda.gov/ola/2001/compassionateuse0620.html|archive-date = August 20, 2001|publisher = U.S. Food and Drug Administration}}</ref><ref>{{cite news| url=http://www.cbsnews.com/news/controversial-compassionate-use-03-05-2001/ | title=Controversial Compassionate Use | date=May 3, 2001|access-date = December 25, 2013|work = [[60 Minutes]]|publisher = CBS| archive-url = https://web.archive.org/web/20131226192517/http://www.cbsnews.com/news/controversial-compassionate-use-03-05-2001/ | archive-date = 2013-12-26| url-status=live}}</ref><ref>{{cite web| url=http://www.webmd.com/healthy-aging/news/20010620/dying-patients-find-experimental-drugs-hard-to-get |title=Dying Patients Find Experimental Drugs Hard to Get |website=[[WebMD]]|date=June 20, 2001|last = Levine|first = Jeff|access-date = December 25, 2013|department = WebMD News Archive| archive-url = https://web.archive.org/web/20131226065731/http://www.webmd.com/healthy-aging/news/20010620/dying-patients-find-experimental-drugs-hard-to-get | archive-date = 2013-12-26| url-status=live}}</ref><ref>{{cite news| url=http://www.boston.com/yourlife/health/diseases/articles/2003/09/23/for_some_untested_drug_is_a_last_chance/ |title=For some, untested drug is a last chance. |date=September 23, 2003|last = Foreman|first = Judy|work = [[The Boston Globe]]|access-date = December 25, 2013| archive-url = https://web.archive.org/web/20121005060255/http://www.boston.com/yourlife/health/diseases/articles/2003/09/23/for_some_untested_drug_is_a_last_chance/ | archive-date = 2012-10-05| url-status=live}}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)